United Kingdom · Regional Lead · 2026-10-21
UK reports shorter setup times for commercial clinical trials
Government data put the average at 100 days for the three months to March, down from 153 days a year earlier.
The UK government reported on October 21 that the average setup time for commercial clinical trials fell to 100 days in the three months through March 2026, compared with 153 days in the equivalent period a year earlier. The measure covers how quickly trial sites become ready, not how long an entire study takes.
All 24 commercial trials in that three-month group were set up within 150 days. The government also says every study receiving combined Medicines and Healthcare products Regulatory Agency and research-ethics approval in September was approved within 60 days.
Examples cited include a group B streptococcus vaccine study that moved into operation in less than 150 days and a Moderna study that recruited 2,500 volunteers in nine weeks. Those examples describe process and recruitment milestones; they do not establish that an experimental treatment is effective or approved for routine use.
More News
World · 2026-10-21
EU Council sets negotiating position on digital-rule changes
The mandate covers privacy, cookies, research data and cyber-incident reporting but still requires negotiations with Parliament.
The Council of the European Union agreed on October 21 to a negotiating position for proposed changes to data-protection, privacy and cybersecurity rules. The mandate is not final legislation. Negotiations can begin after the European Parliament adopts its own position.
The Council text would clarify how pseudonymisation and identification relate to personal data, simplify handling of excessive requests and adjust certain information duties in low-risk cases. It also proposes a principle-based definition of scientific research and targeted exemptions intended to make research-data processing more consistent.
Read articleEnvironment · 2026-10-20
EU institutions reach provisional carbon-market reserve agreement
The compromise would raise the allowance-invalidation threshold to 700 million while leaving the reserve’s broader design intact.
The Council of the European Union and European Parliament reached a provisional agreement on October 20 to revise one part of the emissions-trading system’s market stability reserve. The deal must still be endorsed and formally adopted by both institutions before the new rule can take effect.
The reserve is intended to manage imbalances in the carbon market by absorbing excess emission allowances or releasing allowances when conditions warrant. The targeted amendment addresses the invalidation mechanism, which permanently removes allowances above a specified level rather than changing the overall design of the reserve.
Read article